- About MMC
- Contract Process
- How to Use
- Application for Material Transfer
- Events
- Laws and Guidelines related to Material Transfer
- My Page
to get the detailed information about the material.| Material number |
Category | Name | Function | Intellectual property rights |
Price | Order or Joint Research Request |
|---|---|---|---|---|---|---|
| KYU QM2020-0127 |
Antibody (hybridoma) |
ObA7
|
Hybridoma producing monoclonal antibody specific to rat osteoblast-specific cell surface A7 antigen | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0126 |
Antibody (hybridoma) |
iKat1-D34
|
Hybridoma producing monoclonal antibody specific to rat osteoclast-specific cell surface antigen iKat1-D34 | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0125 |
Antibody (hybridoma) |
iKat1-C71
|
hybridoma producing anti-rat osteoclast-specific monoclonal antibody recognizing iKat1-C71 antigen, rat osteoclast specific cell surface antigen | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0124 |
Antibody (hybridoma) |
iKat1-A37
|
Hybridoma producing monoclonal antibody recognizing rat osteoclast-selective iKat1-A37 antigen | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0123 |
Antibody (hybridoma) |
Kat1
|
anti-Kat1 antigen monoclonal antibody producing hybridoma (producing monoclonal antibody recognizing rat osteoclast-specific cell surface antigen:Kat1antigen) | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0121 |
Animal and Cell line from human (cell strain/cell line) |
RAW-D cell
|
murine osteoclast precursor cell line (bearing high sensitivity to RANKL, osteoclast differentiation factor) | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0114 |
Animal and Cell line from human (cell strain/cell line) |
mitochondria p32 knockout MEF cells
|
mitochondrial RNA and protein chaperon for mitochondrial translation | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0109 |
Chemical Compound (organic compound) |
oxygenated cholesterol
|
20-Hydroxycholesterol, 17-Hydroxycholesterol, 14-Hydroxycholesterol, 15-Hydroxycholesterol, 16-Hydroxycholesterol, 20,25-Dihydroxycholesterol, 17,25-Dihydroxycholesterol, 14,25-Dihydroxycholesterol, etc | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0108 |
Animal and Cell line from human (animal) |
RANKL-Cre KI
|
Cre expression under Tnfsf11 (RANKL) promotor | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2020-0107 |
Animal and Cell line from human (cell strain/cell line) |
U2OS 40-2-6
|
U2OS cell with lacO array and ER-LacI gene generated from U2OS 2-6-3 cells | None |
Academia: Cost of transaction Company: Negotiable |
|
| ｜＜ ＜ 6 7 8 9 10 11 12 13 14 15 ＞ ＞｜ | ||||||
Links